Clinical and Hematological Manifestation of Dengue Patients in 2022 Outbreak: A Tertiary Care Hospital‐Based Cross‐Sectional Study
Health Science Reports · 2025-01 · 8 (1)
DOI: 10.1002/hsr2.70356 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Science Reports, online erschienen am 17.01.2025. Verfasst von Md Jubayer Hossain und 4 weiteren Autor:innen. Beteiligte Einrichtung: Population Health Studies Division Center for Health Innovation, Research, Action, and Learning-Bangladesh (CHIRAL Bangladesh) Dhaka Bangladesh. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and Aims Dengue is a mosquito‐borne viral disease that frequently causes seasonal outbreaks in Bangladesh, particularly during the monsoon months from June to September. Recent outbreaks have shown significant shifts in clinical manifestations, including changes in the timeframe and serotype mixing. This study focused on the clinical and hematological profiles of patients during the 2022 outbreak, which was notably severe.
Methods
This quantitative cross‐sectional study at Dhaka Medical College and Hospital classified 67 dengue‐positive patients as having dengue fever (DF), dengue fever with warning signs (DFWS), and severe dengue (SD). Fisher's exact test, Pearson's chi‐squared test, and Wilcoxon rank‐sum test were conducted for statistical analysis using the R software (version 4.2), with significance established at p < 0.05.
Results
Predominantly male patients (76%) aged 21−40 (63%) and middle‐class patients from Dhaka (57%) formed the majority. Most patients (45%) lacked a regular drainage system. Laboratory tests showed 63% NS1 antigen (nonspecific antigen 1) positivity, and 16% tested positive for both NS1 and IgM (Immunoglobulin M). Symptoms included headache (84%), retroorbital pain (51%), joint pain (75%), myalgia (72%), vomiting (75%), abdominal pain (69%), diarrhea (39%), and shock (48%). Thrombocytopenia was present in 61% of patients, with 79% showing elevated hematocrit (HCT) levels. Pedal edema, pleural effusion, and ascites were observed in DF and DFWS cases, while SD cases exhibited distinct HCT level variations.
Conclusion
Accurate clinical and laboratory assessments are vital for the treatment and prediction of dengue outcomes in Bangladesh, given the severe manifestations of dengue shock syndrome (DSS). It is characterized by headache, muscle pain, thrombocytopenia, anemia, leukopenia, and potential neurological complications or mortality. Severe cases involve critical plasma leakage, leading to DSS with fluid accumulation, respiratory distress, and potential multiorgan involvement. Enhancing physician awareness regarding dengue case detection and management, along with routine dengue testing, are recommended for early diagnosis and improved patient outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Population Health Studies Division Center for Health Innovation, Research, Action, and Learning-Bangladesh (CHIRAL Bangladesh) Dhaka Bangladesh.
- Dhaka Medical College and Hospital Dhaka Bangladesh.
- Department of Microbiology Jagannath University Dhaka Bangladesh.
ORCID-Profile: Md Jubayer Hossain, Manisha Das, Syeda Tasneem Towhid
Zitieren
APA
Hossain, M. J., Das, M., Shahjahan, M., Islam, M. W., & Towhid, S. T. (2025). Clinical and Hematological Manifestation of Dengue Patients in 2022 Outbreak: A Tertiary Care Hospital‐Based Cross‐Sectional Study. Health Science Reports, 8(1). https://doi.org/10.1002/hsr2.70356
Vancouver
Hossain MJ, Das M, Shahjahan M, Islam MW, Towhid ST. Clinical and Hematological Manifestation of Dengue Patients in 2022 Outbreak: A Tertiary Care Hospital‐Based Cross‐Sectional Study. Health Science Reports. 2025;8(1). doi:10.1002/hsr2.70356
BibTeX
@article{Hossain2025,
author = {Hossain, Md Jubayer and Das, Manisha and Shahjahan, Muhibullah and Islam, Md Wahidul and Towhid, Syeda Tasneem},
title = {Clinical and Hematological Manifestation of Dengue Patients in 2022 Outbreak: A Tertiary Care Hospital‐Based Cross‐Sectional Study},
journal = {Health Science Reports},
year = {2025},
volume = {8},
number = {1},
doi = {10.1002/hsr2.70356}
}
EUVIMED